These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections. Melo LD; Veiga P; Cerca N; Kropinski AM; Almeida C; Azeredo J; Sillankorva S Front Microbiol; 2016; 7():1024. PubMed ID: 27446059 [TBL] [Abstract][Full Text] [Related]
43. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480 [TBL] [Abstract][Full Text] [Related]
44. Using Bacteriophages as a Trojan Horse to the Killing of Dual-Species Biofilm Formed by Tkhilaishvili T; Wang L; Perka C; Trampuz A; Gonzalez Moreno M Front Microbiol; 2020; 11():695. PubMed ID: 32351494 [No Abstract] [Full Text] [Related]
45. Decreased Pseudomonas aeruginosa biofilm formation on nanomodified endotracheal tubes: a dynamic lung model. Machado MC; Webster TJ Int J Nanomedicine; 2016; 11():3825-31. PubMed ID: 27563242 [TBL] [Abstract][Full Text] [Related]
46. Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-l-Lysine. Guillon A; Fouquenet D; Morello E; Henry C; Georgeault S; Si-Tahar M; Hervé V Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104272 [TBL] [Abstract][Full Text] [Related]
47. Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro. Pericolini E; Colombari B; Ferretti G; Iseppi R; Ardizzoni A; Girardis M; Sala A; Peppoloni S; Blasi E BMC Microbiol; 2018 Aug; 18(1):84. PubMed ID: 30107778 [TBL] [Abstract][Full Text] [Related]
48. Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant Camens S; Liu S; Hon K; Bouras GS; Psaltis AJ; Wormald PJ; Vreugde S Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576896 [TBL] [Abstract][Full Text] [Related]
49. Investigating the biocontrol and anti-biofilm potential of a three phage cocktail against Cronobacter sakazakii in different brands of infant formula. Endersen L; Buttimer C; Nevin E; Coffey A; Neve H; Oliveira H; Lavigne R; O'Mahony J Int J Food Microbiol; 2017 Jul; 253():1-11. PubMed ID: 28460269 [TBL] [Abstract][Full Text] [Related]
50. Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models. Kwiatek M; Parasion S; Rutyna P; Mizak L; Gryko R; Niemcewicz M; Olender A; Łobocka M Res Microbiol; 2017 Apr; 168(3):194-207. PubMed ID: 27818282 [TBL] [Abstract][Full Text] [Related]
51. Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm. Danis-Wlodarczyk K; Olszak T; Arabski M; Wasik S; Majkowska-Skrobek G; Augustyniak D; Gula G; Briers Y; Jang HB; Vandenheuvel D; Duda KA; Lavigne R; Drulis-Kawa Z PLoS One; 2015; 10(5):e0127603. PubMed ID: 25996839 [TBL] [Abstract][Full Text] [Related]
52. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Chegini Z; Khoshbayan A; Taati Moghadam M; Farahani I; Jazireian P; Shariati A Ann Clin Microbiol Antimicrob; 2020 Sep; 19(1):45. PubMed ID: 32998720 [TBL] [Abstract][Full Text] [Related]
53. Micro-patterned surfaces reduce bacterial colonization and biofilm formation in vitro: Potential for enhancing endotracheal tube designs. May RM; Hoffman MG; Sogo MJ; Parker AE; O'Toole GA; Brennan AB; Reddy ST Clin Transl Med; 2014; 3():8. PubMed ID: 24739529 [TBL] [Abstract][Full Text] [Related]
54. Cocktail, a Computer Program for Modelling Bacteriophage Infection Kinetics. Nilsson AS Viruses; 2022 Nov; 14(11):. PubMed ID: 36366581 [TBL] [Abstract][Full Text] [Related]
56. Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation. Rello J; Afessa B; Anzueto A; Arroliga AC; Olson ME; Restrepo MI; Talsma SS; Bracken RL; Kollef MH Crit Care Med; 2010 Apr; 38(4):1135-40. PubMed ID: 20081533 [TBL] [Abstract][Full Text] [Related]
57. Antibacterial Efficacy of Two Commercially Available Bacteriophage Formulations, Staphylococcal Bacteriophage and PYO Bacteriophage, Against Methicillin-Resistant Tkhilaishvili T; Wang L; Tavanti A; Trampuz A; Di Luca M Front Microbiol; 2020; 11():110. PubMed ID: 32117136 [TBL] [Abstract][Full Text] [Related]
58. The Biofilm Inhibition Properties of Glucosamine Gold Nanoparticles in Combination with Meropenem against Santosaningsih D; Mulyastuti Y; Poejiani S; Putri RF; Dewi L; Arifani H; Ni'mah YL; Baktir A Materials (Basel); 2024 Mar; 17(7):. PubMed ID: 38612117 [TBL] [Abstract][Full Text] [Related]